Fresenius Kabi – Recall of vecuronium injection
January 16, 2018 - Fresenius Kabi announced a user level recall of one lot of vecuronium bromide 10 mg injection due to an out-of-specification (OOS) result for a compound at the 12 month stability test. The affected compound is an active metabolite of vecuronium bromide.
Top